Therapy Areas: AIDS & HIV
Oracle partners with NIH to support vaccine trials in fight against COVID-19
17 July 2020 -

Oracle Corporation (NYSE:ORCL) announced on Thursday that it is working with the National Institutes of Health (NIH) to support COVID-19 vaccine trials.

The National Institute of Allergy and Infectious Diseases (NIAID), part of NIH, recently established the COVID-19 Prevention Network (CoVPN). Its goal is to register millions of volunteers for large-scale clinical testing of vaccines and monoclonal antibodies intended to protect people from COVID-19.

As part of this initiative, Oracle has developed a cloud system called the CoVPN Volunteer Screening Registry to identify and screen volunteers who want to participate in COVID-19 clinical trials. More than 100,000 people have registered since the system went live a week ago.

The program is expected to support hundreds of clinical trial sites across the United States and internationally by the end of the year, Oracle said.

Login
Username:

Password: